Literature DB >> 19947070

Chronic opioid therapy issues associated with opioid abuse potential.

Howard S Smith1, Kenneth L Kirsh, Steven D Passik.   

Abstract

Chronic opioid therapy continues to be an important "mainstream" option for the relief of pain, despite continued debate over the efficacy and safety of utilizing opioids with chronic noncancer populations. With this increase in utilization for medical purposes, the authors have also experienced a troubling rise in the abuse and diversion of prescription opioids. Providers should note this relationship and always perform due diligence when assessing whether a patient with chronic noncancer pain is an appropriate candidate for opioid therapy based on potential risk factors. Because of the relative shortage of board-certified pain practitioners in the United States, much of the practice of pain management falls on primary care providers, who might feel uncomfortable or overwhelmed when facing these issues. To this end, a set of guidelines are discussed to promote an approach to chronic noncancer pain utilizing "universal precautions" principles. In addition, several risk tools are evaluated, including the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R), the Opioid Risk Tool (ORT), and the Pain Assessment and Documentation Tool (PADT). Finally, discussion is presented regarding what practices seen in opioid prescribing can be considered "in-or-out" of the mainstream box.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19947070     DOI: 10.5055/jom.2009.0029

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  8 in total

Review 1.  Opioid use in primary care: asking the right questions.

Authors:  Eleanor T Lewis; Jodie A Trafton
Journal:  Curr Pain Headache Rep       Date:  2011-04

Review 2.  Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management.

Authors:  Christina Nicolaidis
Journal:  Pain Med       Date:  2011-05-03       Impact factor: 3.750

Review 3.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

Review 4.  Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Authors:  Stephen Bruehl; A Vania Apkarian; Jane C Ballantyne; Ann Berger; David Borsook; Wen G Chen; John T Farrar; Jennifer A Haythornthwaite; Susan D Horn; Michael J Iadarola; Charles E Inturrisi; Lixing Lao; Sean Mackey; Jianren Mao; Andrea Sawczuk; George R Uhl; James Witter; Clifford J Woolf; Jon-Kar Zubieta; Yu Lin
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

5.  Psychosocial factors predict opioid analgesia through endogenous opioid function.

Authors:  John W Burns; Stephen Bruehl; Christopher R France; Erik Schuster; Daria Orlowska; Asokumar Buvanendran; Melissa Chont; Rajnish K Gupta
Journal:  Pain       Date:  2017-03       Impact factor: 7.926

6.  A Review of Select Centralized Pain Syndromes: Relationship With Childhood Sexual Abuse, Opiate Prescribing, and Treatment Implications for the Primary Care Physician.

Authors:  David R Spiegel; Aparna Chatterjee; Aidan L McCroskey; Tamana Ahmadi; Drew Simmelink; Edward C Oldfield; Christopher R Pryor; Michael Faschan; Olivia Raulli
Journal:  Health Serv Res Manag Epidemiol       Date:  2015-01-26

Review 7.  Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product.

Authors:  Joseph V Pergolizzi; Robert Taylor; Jo Ann LeQuang; Robert B Raffa
Journal:  J Pain Res       Date:  2018-02-08       Impact factor: 3.133

8.  Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users.

Authors:  Beatrice Setnik; Almasa Bass; Candace Bramson; Naama Levy-Cooperman; Bimal Malhotra; Kyle Matschke; Pierre Geoffroy; Kenneth W Sommerville; Gernot Wolfram
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.